Michael James Waring
25Patents
6h-index
45Co-inventors
69Inventor score
Filing activity: Jul 22, 1991 → Jul 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7642263B2 | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes | Chemistry; Metallurgy | 8 | Active |
| US7642259B2 | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes | Chemistry; Metallurgy | 8 | Active |
| US5906601A | Use of an adhesive composition in the manufacture of a wound dressing | Chemistry; Metallurgy | 7 | Expired |
| US7671060B2 | Heteroaryl benzamide derivatives | Chemistry; Metallurgy | 7 | Active |
| US7745475B2 | Heteroaryl benzamide derivatives as GLK activators | Chemistry; Metallurgy | 7 | Expired |
| US7842694B2 | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes | Chemistry; Metallurgy | 6 | Active |
| US8188092B2 | Substituted pyrazines as DGAT-1 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US5215600A | Thermomechanical treatment of Ti 6-2-2-2-2 | Emerging Cross-Sectional Technologies | 6 | Expired |
| US9944650B2 | [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases | Chemistry; Metallurgy | 3 | Active |
| US7902200B2 | Chemical compounds | Chemistry; Metallurgy | 2 | Active |
| US10407432B2 | [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases | Chemistry; Metallurgy | 2 | Active |
| US10766905B2 | [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases | Chemistry; Metallurgy | 1 | Active |
| US8071608B2 | Therapeutic agents | Human Necessities | 0 | Active |
| US8247562B2 | Benzamide derivatives useful as histone deacetylase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8143263B2 | Therapeutic agents | Human Necessities | 0 | Active |
| US7964725B2 | Heteroarylbenzamide derivatives for use in the treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US7977328B2 | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US11407755B2 | [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases | Chemistry; Metallurgy | 0 | Active |
| US10821203B2 | Composition and dressing with nitric oxide | Human Necessities | 0 | Active |
| US7943607B2 | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US8207202B2 | Benzamide compounds useful as histone deacetylase inhibitors | Human Necessities | 0 | Active |
| US10835636B2 | Composition and dressing with nitric oxide | Human Necessities | 0 | Active |
| US7897778B2 | Benzamide compounds | Chemistry; Metallurgy | 0 | Active |
| US8071585B2 | Therapeutic agents | Human Necessities | 0 | Active |
| US8735429B2 | Benzamide compounds useful as histone deacetylase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.